Navigation Links
Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
Date:12/20/2007

s a Greenwich, CT based private equity firm founded in early 2005 by David S. Wetherell, founder and former CEO of CMGI and innovator in the technology and Internet industries. GBP Capital's mission is to improve the human condition by providing venture funding and assistance to the most promising early to mid-stage life science companies. GBP targets companies with novel approaches to diagnostics, therapeutics, and medical devices that will change the face of healthcare innovation in the future. For additional information, please visit the company's website at http://www.gbpcap.com .

About GBP IP, LLC

GBP IP, LLC is the privately held intellectual property affiliate of GBP Capital.

Cell Genesys Forward-looking Statement

Statements made herein about the company, other than statements of historical fact, including statements about the company's progress, results and timing of clinical trials and preclinical programs and the nature of product pipelines are forward-looking statements and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made, including risks associated with the success of clinical trials and research and development programs, regulatory requirements and the regulatory approval process for clinical trials, manufacture and commercialization of the company's products, competitive technologies and products, patents, the need for and reliance on partnerships with third parties, and the need for additional financings. For information about these and other risks which may affect Cell Genesys, please see the company's Annual Report on Form 10-K for the year ended December 31, 2006 filed on March 1, 2007 as well as Cell Genesys' reports on Form 10-Q and 8-K and other reports filed from time to time with the Securities and Exchange Commission. The company assumes no obligation to update the forward-looking information in t
'/>"/>

SOURCE Cell Genesys, Inc.; GBP IP, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Cell Genesys to Present at the BIO Investor Forum
3. Cell Genesys to Webcast Third Quarter 2007 Conference Call
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for the ... make a statement with fashion, many change their makeup to ... mixes makeup and sweat to produce, and increase acne breakouts. ... warmer months, Adult Acne treatment , Probiotic Action shares ... to deter breakouts. , Recently, an article from ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ...   Competitor Analysis: ... Biosuperiors http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The ...
(Date:5/16/2013)... BioInformatics LLC New Market Report – ... Current and Future Opportunities (13-004) , With barriers ... primary cells market continues to increase. In this study, ... often, how satisfied scientists are with commercially available primary ... rate. ,  , Additionally, terminally differentiated cells can ...
(Date:5/16/2013)... 2013 Dr. Stephen Y. Chou, Founder ... “Nanoimprint Lithography and Applications” at IEEE Nano 2013 in ... in 1995 by Chou, is becoming one of the ... combination of sub-10 nm resolution, large area, and low ... both R&D and manufacturing in a broad range of ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... FRANKLIN LAKES, N.J., March 27 BD (Becton,Dickinson ... global medical technology,company, and Direct Relief International, a ... joint volunteer,initiative to strengthen healthcare in Ghana. A ... to Ghana for three weeks and work side-by-side,with ...
... Siemens Will Showcase Its Portfolio of Cardiovascular ... Healthcare, (http://www.usa.siemens.com/healthcare ) will demonstrate how its ... are helping,to "Bring a New Rhythm to ... of the American College of Cardiology (ACC) ...
... Aimed at Developing New Screening Methods and Holds Significant, Potential for Early ... ... Killer, - Biomarker Project holds significant potential for new screening ... the disease before even the ...
Cached Biology Technology:BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 2BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 3Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 2Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 3Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 4Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 5Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project 2Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project 3
(Date:5/16/2013)... years old give unprecedented insight into the evolutionary ... most species-rich groups among the modern bony fishes. ... from the Division of Paleontology and Geobiology at ... Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have completed ... assign to the group of bony fishes that ...
(Date:5/16/2013)... in Cameroon and the manager of San Diego Zoo ... prestigious Whitley award. The Whitley award is an ... because it celebrates the extraordinary achievements of some of ... Abwe was selected for the award due to his ... and its wildlife inhabitants., HRH The Princess Royal, the ...
(Date:5/15/2013)... in moderating gout risk, new research reveals that vitamin ... acid (urate) levels to a clinically significant degree in ... in combination with allopurinol, appears to have a weak ... according to the results published in the American College ... , Gout is an inflammatory arthritis that causes ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2
... Nov. 1, 2011Researchers at St. Michael,s Hospital have identified ... They also identified two possible treatments to prevent ... the development of new drugs to treat heart attacks ... Ni, found that the same kind of blood-clotting in ...
... people can exchange information instantaneously in the digital age, ... freely and rapidly exchange genetic material related to human ... gene transfer (HGT). In a paper appearing in ... by Eric Alm of MIT,s Department of Civil and ...
... Chinese Academy of Sciences found one new species, Aleurodaphis sinojackiae ... forms leaf galls on Jack trees ( Sinojackia xylocarpa ) and is ... ( Hemiptera , Aphididae , Hormaphidinae ). The ... . Aleurodaphis was established in 1917 by van der ...
Cached Biology News:Researchers pinpoint possible new cause for unexplained miscarriages 2MIT: Bacteria may readily swap beneficial genes 2MIT: Bacteria may readily swap beneficial genes 3